ABBV — AbbVie Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1551152 ·
Last close
$292.82
Market Cap
$517.59B
52W High
$302.93
52W Low
$188.25
ADV30
5,311,867
Next earnings
2026-10-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 16,990,000,000 | 12,699,000,000 | 6,723,000,000 | 3,613,000,000 | 135,115,000,000 | 6,569,000,000 | 141,003,000,000 |
| Mar 2026 | 15,002,000,000 | 10,784,000,000 | 4,734,000,000 | 695,000,000 | 136,463,000,000 | 9,391,000,000 | 143,075,000,000 |
| Dec 2025 | 16,618,000,000 | 12,066,000,000 | 5,809,000,000 | 1,816,000,000 | 133,960,000,000 | 5,229,000,000 | 137,188,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$20,089,000,000
Investing CF
$-13,449,000,000
Financing CF
$-1,481,000,000
CapEx
$-1,217,000,000
Dividends Paid
$-12,138,000,000
Buybacks
$-1,506,000,000
EPS Diluted TTM
$5.81
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-16,190,000,000
Inventory
$5,305,000,000
Receivables
$13,509,000,000
ST Investments
$28,000,000
EBIT TTM
$15,793,000,000
Pretax Income TTM
$12,814,000,000
Interest Exp TTM
$2,979,000,000
Analysts
26
Yahoo Snapshot (yfinance, live)
Total Revenue
$66,013,999,104
EBITDA
$31,850,999,808
Free Cash Flow
$17,693,124,608
Enterprise Value
$585,512,321,024
Total Cash
$10,773,999,616
Total Debt
$81,317,003,264
Shares Out
1,767,616,306
Trailing EPS
$5.82
Book Value
$-2.59
ROE
—
ROA
10.7%
Div Yield
2.38%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 61,160,000,000 | 20,091,000,000 | 4,226,000,000 | 133,960,000,000 | 137,188,000,000 | -3,270,000,000 | 19,030,000,000 |
| Dec 2024 | 56,334,000,000 | 11,894,000,000 | 4,278,000,000 | 135,161,000,000 | 131,797,000,000 | 3,325,000,000 | 18,806,000,000 |
| Dec 2023 | 54,318,000,000 | 13,535,000,000 | 4,863,000,000 | 134,711,000,000 | 124,314,000,000 | 10,360,000,000 | 22,839,000,000 |
| Dec 2022 | 58,054,000,000 | 18,814,000,000 | 11,836,000,000 | 138,805,000,000 | 121,518,000,000 | 17,254,000,000 | 24,943,000,000 |
TTM Snapshot
Revenues TTM
$64,386,000,000
NetIncome TTM
$6,310,000,000
OpCashFlow TTM
—
Assets (Latest)
$135,115,000,000
Forward EPS
$16.19
Max Pain — expiry 2026-11-27 (volume-derived — Yahoo OI feed degraded)
max pain strike: $287.50 · spot: $286.01 · call volume: 544 · put volume: 4,906
Expected Move to 2026-11-27:
±$9.68
(3.38%) —
implied range
$276.33 –
$295.69
· ATM straddle on $285.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | $670.92B | $278.70 | — |
| MRK | Merck & Co., Inc. | $353.44B | $143.37 | — |
| NVS | NOVARTIS AG | $302.46B | $159.13 | — |
| AZN | ASTRAZENECA PLC | $282.68B | $182.27 | — |
| LLY | ELI LILLY & Co | $1.26T | $1415.55 | — |
News headlines (Yahoo Finance, 1h cache)
DISCO Pharmaceuticals Announces Strategic Collaboration with AbbVie to Advance Next-Generation AND-Gated Bispecific Therapeutics for Solid Tumors
2026-11-19 07:00 · Yahoo
Invest $200,000 in These 5 Dividend Stocks to Fund Your Retirement Income
2026-11-17 16:30 · Yahoo
Drug and Gene Delivery Devices - Global Strategic Business Report 2026: Capitalize on 8.1% CAGR to Secure the $1.2 Billion Market by 2032 as AbbVie, Moderna, Pfizer and Novartis Accelerate
2026-11-17 15:02 · Yahoo
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
2026-11-17 13:00 · Yahoo
AbbVie Is Up 27% in a Year. Barclays Sees Another 14%
2026-11-17 12:53 · Yahoo
iShares Core Dividend Growth (DGRO) Buys $4.2 Million More Apple on Nov. 13
2026-11-17 11:04 · Yahoo
Ken Griffin Dumps SpaceX, Amazon; Buys ARKK and Bets Big on Marvell
2026-11-18 22:30 · Yahoo
Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?
2026-11-17 23:47 · Yahoo
Forget SCHD: 4 Dividend Stocks Retirees Should Own Instead
2026-11-17 14:15 · Yahoo
Is Lilly Stock's Winning Streak Skill Or Luck?
2026-11-18 15:07 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.